chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 20.0
Sex: F
Vaccine: MMR, TDAP, MMR, TDAP
Symptoms: Induration, Inflammation, Injection site nodule, Tenderness
Clinical narrative: Initial report was received 31 March 2011 from a health care professional, who also reported the event to VAERS (temporary VAERS E-Report Number: E-52700). This report contains information for one patient, out of a cluster of two patients, who experienced adverse events after receiving ADACEL, lot number C3540AA. A 20-year-old female patient who had a history of penicillin allergy and who was two days status post cesarean section, had received an intramuscular right arm injection of ADACEL, lot number C3540AA and a left arm injection of MMR II (manufacturer Merck, lot number 077FY, route not reported) on 17 February 2011. On 25 February 2011, eight days after vaccination, the patient presented with inflammation at the injection site, tenderness, a nodule and some induration. There was no cellulitis and no heat. Concomitant medications consisted of Prenatal Vitamins, LORTAB 5, Cefazolin, BICITRA, BENADRYL, MOTRIN, TORADOL, DEMEROL, REGLAN, TYLOX, SENNS S, and MYLANTA Gas. The physician was unaware of any improvement or decline in the patient's outcome since the original report. The patient's recovery status was unknown. Follow-up information was received from the healthcare professional on 09 May 2011. The patient recovered on an unspecified date. Per the reporter, no additional information was available at this time. The reporter for this case is the same as for case number 2011-02011. Documents held by sender: None.
Age: 20.0
Sex: F
Vaccine: MMR, TDAP, MMR, TDAP
Symptoms: Injection site induration, Injection site inflammation, Injection site nodule, Injection site pain
Clinical narrative: Initial report was received 31 March 2011 from a health care professional, who also reported the event to VAERS (temporary VAERS E-Report Number: E-52700). This report contains information for one patient, out of a cluster of two patients, who experienced adverse events after receiving ADACEL, lot number C3540AA. A 20-year-old female patient who had a history of penicillin allergy and who was two days status post cesarean section, had received an intramuscular right arm injection of ADACEL, lot number C3540AA and a left arm injection of MMR II (manufacturer Merck, lot number 077FY, route not reported) on 17 February 2011. On 25 February 2011, eight days after vaccination, the patient presented with inflammation at the injection site, tenderness, a nodule and some induration. There was no cellulitis and no heat. Concomitant medications consisted of Prenatal Vitamins, LORTAB 5, Cefazolin, BICITRA, BENADRYL, MOTRIN, TORADOL, DEMEROL, REGLAN, TYLOX, SENNS S, and MYLANTA Gas. The physician was unaware of any improvement or decline in the patient's outcome since the original report. The patient's recovery status was unknown. Follow-up information was received from the healthcare professional on 09 May 2011. The patient recovered on an unspecified date. Per the reporter, no additional information was available at this time. The reporter for this case is the same as for case number 2011-02011. Documents held by sender: None.
Age: 57.0
Sex: F
Vaccine: TDAP, TDAP, TDAP
Symptoms: Injection site pain, Pain, Pain in extremity, Radiculitis brachial
Clinical narrative: Initial report was received 11 April 2011 from a consumer, who is also the patient. A 57-year-old female patient who had a history of Hashimoto's disease and hyperparathyroidism, had received a right deltoid intramuscular injection of ADACEL, lot number C3828AA on 25 March 2011 and two days later, she developed an intense burning from the injection site to her shoulder. She also experienced pain shooting down her arm and pain in the back of her arm. The event required an emergency room visit and doctor's visit. The patient was seen by a neurologist and diagnosed with brachial neuritis. Corrective treatments consisted of TRAMADOL for pain. The patient had no illness and no known allergies at the time of vaccination. Concomitant therapies consisted of LEVOXYL 100 mg. The patient had not received any other vaccines within four weeks of ADACEL and she denied any history of adverse events following prior vaccinations. Outcome was not recovered. Follow-up information was received from a health care professional on 05 May 2011. The ADACEL injection was administered to the right deltoid with a 3ml 25g 5/8 (0.5x16mm) needle (exact location of top, middle or bottom of deltoid was not known). The patient had no reported history of arm injury and her weight and height was 147 pounds and 64 inches. At the time of vaccination the patient had a hoarse voice, cough and GERD. She had not received any other vaccinations within four weeks of the suspect vaccine. Concomitant medications also included VAGIFORM 10 mcg tabs. According to the reporter, the patient terminated their relationship shortly after receiving the ADACEL vaccination and had no further information to provide. The reporter was unaware of patient's outcome. Documents held by sender: None.
Age: 57.0
Sex: F
Vaccine: TDAP, TDAP, TDAP
Symptoms: Activities of daily living impaired, Headache, Injection site pain, Lymphadenopathy, Mobility decreased
Clinical narrative: Initial report was received 11 April 2011 from a consumer, who is also the patient. A 57-year-old female patient who had a history of Hashimoto's disease and hyperparathyroidism, had received a right deltoid intramuscular injection of ADACEL, lot number C3828AA on 25 March 2011 and two days later, she developed an intense burning from the injection site to her shoulder. She also experienced pain shooting down her arm and pain in the back of her arm. The event required an emergency room visit and doctor's visit. The patient was seen by a neurologist and diagnosed with brachial neuritis. Corrective treatments consisted of TRAMADOL for pain. The patient had no illness and no known allergies at the time of vaccination. Concomitant therapies consisted of LEVOXYL 100 mg. The patient had not received any other vaccines within four weeks of ADACEL and she denied any history of adverse events following prior vaccinations. Outcome was not recovered. Follow-up information was received from a health care professional on 05 May 2011. The ADACEL injection was administered to the right deltoid with a 3ml 25g 5/8 (0.5x16mm) needle (exact location of top, middle or bottom of deltoid was not known). The patient had no reported history of arm injury and her weight and height was 147 pounds and 64 inches. At the time of vaccination the patient had a hoarse voice, cough and GERD. She had not received any other vaccinations within four weeks of the suspect vaccine. Concomitant medications also included VAGIFORM 10 mcg tabs. According to the reporter, the patient terminated their relationship shortly after receiving the ADACEL vaccination and had no further information to provide. The reporter was unaware of patient's outcome. Documents held by sender: None.
Age: 57.0
Sex: F
Vaccine: TDAP, TDAP, TDAP
Symptoms: Muscular weakness, Musculoskeletal stiffness, Pain
Clinical narrative: Initial report was received 11 April 2011 from a consumer, who is also the patient. A 57-year-old female patient who had a history of Hashimoto's disease and hyperparathyroidism, had received a right deltoid intramuscular injection of ADACEL, lot number C3828AA on 25 March 2011 and two days later, she developed an intense burning from the injection site to her shoulder. She also experienced pain shooting down her arm and pain in the back of her arm. The event required an emergency room visit and doctor's visit. The patient was seen by a neurologist and diagnosed with brachial neuritis. Corrective treatments consisted of TRAMADOL for pain. The patient had no illness and no known allergies at the time of vaccination. Concomitant therapies consisted of LEVOXYL 100 mg. The patient had not received any other vaccines within four weeks of ADACEL and she denied any history of adverse events following prior vaccinations. Outcome was not recovered. Follow-up information was received from a health care professional on 05 May 2011. The ADACEL injection was administered to the right deltoid with a 3ml 25g 5/8 (0.5x16mm) needle (exact location of top, middle or bottom of deltoid was not known). The patient had no reported history of arm injury and her weight and height was 147 pounds and 64 inches. At the time of vaccination the patient had a hoarse voice, cough and GERD. She had not received any other vaccinations within four weeks of the suspect vaccine. Concomitant medications also included VAGIFORM 10 mcg tabs. According to the reporter, the patient terminated their relationship shortly after receiving the ADACEL vaccination and had no further information to provide. The reporter was unaware of patient's outcome. Documents held by sender: None.
Age: 36.0
Sex: F
Vaccine: TDAP, TDAP
Symptoms: Back pain, Musculoskeletal stiffness, Neck pain, Pain in jaw, Urticaria
Clinical narrative: Initial report was received from a health care professional on 26 April 2011 who also reported to it to VAERS (Temporary VAERS E-Report Number: E-53067). A 36 year-old health post-partum female patient who had no illnesses at the time of vaccination had received on 20 April 2011 at 1023 AM an intramuscular injection of ADACEL, lot number U3553AA (sanofi pasteur Ltd. lot number C3677) and the next day at 1:00 PM experienced hives, jaw pain and stiffness, back pain and neck pain. The patient required and emergency room/Doctor visit. The patient's pre-existing conditions were reported as none. The patient's outcome was unknown. Documents held by sender: None.
Age: 40.0
Sex: F
Vaccine: FLU3, TDAP, FLU3, TDAP
Symptoms: Asthenia, Fatigue
Clinical narrative: Initial case received from a consumer, who is also the patient, on 28 April 2011. A 40-year-old female patient received ADACEL and influenza vaccine (manufacturer and lot numbers not reported) on 25 April 2011. Within 6 hours post-vaccination, she reported feeling cold, dizzy, severely fatigued, sleepy, tired, and with muscular weakness. She stated that symptoms resolved 3 days later on 28 April 2011. The patient also stated that she had experienced a similar reaction to a Td vaccine which she received on 22 September 2007. Details pertaining to that case are captured in 2011-02558.
Age: 40.0
Sex: F
Vaccine: FLU3, TDAP, FLU3, TDAP
Symptoms: Dizziness, Fatigue, Feeling cold, Muscular weakness, Somnolence
Clinical narrative: Initial case received from a consumer, who is also the patient, on 28 April 2011. A 40-year-old female patient received ADACEL and influenza vaccine (manufacturer and lot numbers not reported) on 25 April 2011. Within 6 hours post-vaccination, she reported feeling cold, dizzy, severely fatigued, sleepy, tired, and with muscular weakness. She stated that symptoms resolved 3 days later on 28 April 2011. The patient also stated that she had experienced a similar reaction to a Td vaccine which she received on 22 September 2007. Details pertaining to that case are captured in 2011-02558.
Age: 21.0
Sex: F
Vaccine: MNQ, TDAP, MNQ, TDAP
Symptoms: Injection site pain, Injection site swelling, Loss of consciousness, Oedema peripheral, Pain in extremity
Clinical narrative: Initial report received from a health care professional on 19 April 2011. A 21-year-old female patient whose medical history was not reported, had received the morning of 18 April 2011 a first intramuscular left deltoid injection of MENACTRA (lot number U3510AA), an intramuscular right deltoid injection of a TDAP vaccine (trade name and manufacturer unknown, lot number, route and site of administration not reported), and a TB (tuberculin) test (trade name, manufacturer name, lot number, route and site of administration not reported). The same day, the patient called the health department to report that she had blacked out for 1 minute, and that her left arm was sore and swollen up to her shoulder. The patient required a doctor visit, however the results of that visit were not provided. The reporter did not have the patient's record at time of reporting, but will provide further information in follow-up. At the time of this report, the patient had not recovered. Additional information has been requested. Follow-up information was received 13 May 2011 from a health care professional. The reporter confirmed that the TdaP vaccine received by the patient was ADACEL, lot number U3487BA (corresponding sanofi pasteur Ltd lot number C3636) which had been administered in the patient's right deltoid and MENACTRA had been administered in the patient's left deltoid. Tuberculin PPD, lot number 300327 (invalid sanofi pasteur lot number), was administered subcutaneously in the left forearm. The patient was vaccinated at 9:00 am on 18 April 2011. On the morning of 19 April 2011, the patient called the reporter to report that on the evening of 18 April 2011, she blacked out. The black out did not require an emergency visit or physician's visit. The patient also complained of nausea, lightheaded, and a sore left deltoid that was red and warm to touch. On 19 April 2011, she was seen by her primary medical doctor (PMD) who told her it was "just a local reaction". The patient had no significant problems on 19 April 2011. On 20 April 2011, the patient returned to have her TB test site read and stated she was "feeling okay". Her arm was no longer red or sore at the left deltoid and there was no mention of anymore black-outs. The reported events did not require any treatment medications. According to the reporter, the patient recovered. Documents held by sender: None.
Age: 21.0
Sex: F
Vaccine: MNQ, TDAP, MNQ, TDAP
Symptoms: Dizziness, Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Initial report received from a health care professional on 19 April 2011. A 21-year-old female patient whose medical history was not reported, had received the morning of 18 April 2011 a first intramuscular left deltoid injection of MENACTRA (lot number U3510AA), an intramuscular right deltoid injection of a TDAP vaccine (trade name and manufacturer unknown, lot number, route and site of administration not reported), and a TB (tuberculin) test (trade name, manufacturer name, lot number, route and site of administration not reported). The same day, the patient called the health department to report that she had blacked out for 1 minute, and that her left arm was sore and swollen up to her shoulder. The patient required a doctor visit, however the results of that visit were not provided. The reporter did not have the patient's record at time of reporting, but will provide further information in follow-up. At the time of this report, the patient had not recovered. Additional information has been requested. Follow-up information was received 13 May 2011 from a health care professional. The reporter confirmed that the TdaP vaccine received by the patient was ADACEL, lot number U3487BA (corresponding sanofi pasteur Ltd lot number C3636) which had been administered in the patient's right deltoid and MENACTRA had been administered in the patient's left deltoid. Tuberculin PPD, lot number 300327 (invalid sanofi pasteur lot number), was administered subcutaneously in the left forearm. The patient was vaccinated at 9:00 am on 18 April 2011. On the morning of 19 April 2011, the patient called the reporter to report that on the evening of 18 April 2011, she blacked out. The black out did not require an emergency visit or physician's visit. The patient also complained of nausea, lightheaded, and a sore left deltoid that was red and warm to touch. On 19 April 2011, she was seen by her primary medical doctor (PMD) who told her it was "just a local reaction". The patient had no significant problems on 19 April 2011. On 20 April 2011, the patient returned to have her TB test site read and stated she was "feeling okay". Her arm was no longer red or sore at the left deltoid and there was no mention of anymore black-outs. The reported events did not require any treatment medications. According to the reporter, the patient recovered. Documents held by sender: None.
Age: 21.0
Sex: F
Vaccine: MNQ, TDAP, MNQ, TDAP
Symptoms: Local reaction, Loss of consciousness, Nausea, Oedema peripheral, Pain in extremity
Clinical narrative: Initial report received from a health care professional on 19 April 2011. A 21-year-old female patient whose medical history was not reported, had received the morning of 18 April 2011 a first intramuscular left deltoid injection of MENACTRA (lot number U3510AA), an intramuscular right deltoid injection of a TDAP vaccine (trade name and manufacturer unknown, lot number, route and site of administration not reported), and a TB (tuberculin) test (trade name, manufacturer name, lot number, route and site of administration not reported). The same day, the patient called the health department to report that she had blacked out for 1 minute, and that her left arm was sore and swollen up to her shoulder. The patient required a doctor visit, however the results of that visit were not provided. The reporter did not have the patient's record at time of reporting, but will provide further information in follow-up. At the time of this report, the patient had not recovered. Additional information has been requested. Follow-up information was received 13 May 2011 from a health care professional. The reporter confirmed that the TdaP vaccine received by the patient was ADACEL, lot number U3487BA (corresponding sanofi pasteur Ltd lot number C3636) which had been administered in the patient's right deltoid and MENACTRA had been administered in the patient's left deltoid. Tuberculin PPD, lot number 300327 (invalid sanofi pasteur lot number), was administered subcutaneously in the left forearm. The patient was vaccinated at 9:00 am on 18 April 2011. On the morning of 19 April 2011, the patient called the reporter to report that on the evening of 18 April 2011, she blacked out. The black out did not require an emergency visit or physician's visit. The patient also complained of nausea, lightheaded, and a sore left deltoid that was red and warm to touch. On 19 April 2011, she was seen by her primary medical doctor (PMD) who told her it was "just a local reaction". The patient had no significant problems on 19 April 2011. On 20 April 2011, the patient returned to have her TB test site read and stated she was "feeling okay". Her arm was no longer red or sore at the left deltoid and there was no mention of anymore black-outs. The reported events did not require any treatment medications. According to the reporter, the patient recovered. Documents held by sender: None.
Age: 42.0
Sex: F
Vaccine: MMR, VARCEL, MMR, VARCEL
Symptoms: Dysphonia, Feeling jittery, Throat irritation, Throat tightness
Clinical narrative: Information has been received from a 42 year old female registered nurse reporting on herself, with reflex sympathetic dystrophy, latex and tetracycline allergy, who on 29-JUN-2011 was vaccinated with a 0.5ml dose of VARIVAX (Merck) subcutaneously (Lot number not reported). Suspect secondary therapy included a dose of MMR II administered on the same day on 29-JUN-2011. Concomitant therapy included amitriptyline hydrochloride (manufacturer unknown), ZANAFLEX, VICOPROFEN, diclofenac and XANAX. The registered nurse reported that on 29-JUN-2011 she experienced her throat getting tight while she was in the parking lot of the health department after receiving the doses of VARIVAX (Merck) and MMR II. She went back into the health department and was given epinephrine. It was reported that the emergency squad was called and she was taken to the emergency room. In the ambulance the registered nurse was treated with BENADRYL. Famotidine and SOLU-MEDROL were given as a treatment in the emergency room and then the registered nurse was discharged to home. No lab diagnostics studies were performed. She reported that today, on 30-JUN-2011 her face was bright red. At the time of the report, the registered nurse was recovering. Upon internal review, throat getting tight was considered to be an other important medical event because the patient was treated with epinephrine. Additional information has been requested.
Age: 42.0
Sex: F
Vaccine: MMR, VARCEL, MMR, VARCEL
Symptoms: Erythema, Throat tightness
Clinical narrative: Information has been received from a 42 year old female registered nurse reporting on herself, with reflex sympathetic dystrophy, latex and tetracycline allergy, who on 29-JUN-2011 was vaccinated with a 0.5ml dose of VARIVAX (Merck) subcutaneously (Lot number not reported). Suspect secondary therapy included a dose of MMR II administered on the same day on 29-JUN-2011. Concomitant therapy included amitriptyline hydrochloride (manufacturer unknown), ZANAFLEX, VICOPROFEN, diclofenac and XANAX. The registered nurse reported that on 29-JUN-2011 she experienced her throat getting tight while she was in the parking lot of the health department after receiving the doses of VARIVAX (Merck) and MMR II. She went back into the health department and was given epinephrine. It was reported that the emergency squad was called and she was taken to the emergency room. In the ambulance the registered nurse was treated with BENADRYL. Famotidine and SOLU-MEDROL were given as a treatment in the emergency room and then the registered nurse was discharged to home. No lab diagnostics studies were performed. She reported that today, on 30-JUN-2011 her face was bright red. At the time of the report, the registered nurse was recovering. Upon internal review, throat getting tight was considered to be an other important medical event because the patient was treated with epinephrine. Additional information has been requested.
Age: 1.11
Sex: M
Vaccine: MMR, MMR
Symptoms: Abscess, Abscess drainage, Culture, Erythema, Full blood count
Clinical narrative: Information has been received from a registered nurse concerning a 13 month old male patient whose father was a methicillin-resistant staphylococcal aureus carrier. On 31-MAY-2011, the patient was vaccinated with a dose of MMR II (lot number: 667245/0961Z, expiration date: 21-JUL-2012) (dose and site of administration not reported). On approximately 07-JUN-2011, about a week after vaccination, the patient developed swollen neck glands and fever. The fever was in the 101 to 104 F range. On 17-JUN-2011, the patient was still experiencing fevers. On 19-JUN-2011, the physician started the patient on amoxicillin. The patient was still experiencing fevers of 103 to 104F and his neck was still swollen, red and tender. The patient was switched to AUGMENTIN. On 21-JUN-2011, the patient was admitted to the hospital. While hospitalized the patient had an abscess in his right lymph node drained (results not provided), strep culture was performed, and high white blood count showed 30, 000. The patient was discharged on 23-JUN-2011. The events were considered medically significant by registered nurse because they required intervention to prevent serious criteria. At the time of the report, the patient was recovering. Additional information has been requested.
Age: 1.11
Sex: M
Vaccine: MMR, MMR
Symptoms: Incisional drainage, Lymph node pain, Lymphadenitis, Lymphadenopathy, Pyrexia
Clinical narrative: Information has been received from a registered nurse concerning a 13 month old male patient whose father was a methicillin-resistant staphylococcal aureus carrier. On 31-MAY-2011, the patient was vaccinated with a dose of MMR II (lot number: 667245/0961Z, expiration date: 21-JUL-2012) (dose and site of administration not reported). On approximately 07-JUN-2011, about a week after vaccination, the patient developed swollen neck glands and fever. The fever was in the 101 to 104 F range. On 17-JUN-2011, the patient was still experiencing fevers. On 19-JUN-2011, the physician started the patient on amoxicillin. The patient was still experiencing fevers of 103 to 104F and his neck was still swollen, red and tender. The patient was switched to AUGMENTIN. On 21-JUN-2011, the patient was admitted to the hospital. While hospitalized the patient had an abscess in his right lymph node drained (results not provided), strep culture was performed, and high white blood count showed 30, 000. The patient was discharged on 23-JUN-2011. The events were considered medically significant by registered nurse because they required intervention to prevent serious criteria. At the time of the report, the patient was recovering. Additional information has been requested.
Age: 1.11
Sex: M
Vaccine: MMR, MMR
Symptoms: Abscess drainage, Culture, Erythema, Local swelling, Lymph node abscess
Clinical narrative: Information has been received from a registered nurse concerning a 13 month old male patient whose father was a methicillin-resistant staphylococcal aureus carrier. On 31-MAY-2011, the patient was vaccinated with a dose of MMR II (lot number: 667245/0961Z, expiration date: 21-JUL-2012) (dose and site of administration not reported). On approximately 07-JUN-2011, about a week after vaccination, the patient developed swollen neck glands and fever. The fever was in the 101 to 104 F range. On 17-JUN-2011, the patient was still experiencing fevers. On 19-JUN-2011, the physician started the patient on amoxicillin. The patient was still experiencing fevers of 103 to 104F and his neck was still swollen, red and tender. The patient was switched to AUGMENTIN. On 21-JUN-2011, the patient was admitted to the hospital. While hospitalized the patient had an abscess in his right lymph node drained (results not provided), strep culture was performed, and high white blood count showed 30, 000. The patient was discharged on 23-JUN-2011. The events were considered medically significant by registered nurse because they required intervention to prevent serious criteria. At the time of the report, the patient was recovering. Additional information has been requested.
Age: 1.11
Sex: M
Vaccine: MMR, MMR
Symptoms: Lymphadenopathy, Pyrexia, Streptococcus test, Tenderness, White blood cell count increased
Clinical narrative: Information has been received from a registered nurse concerning a 13 month old male patient whose father was a methicillin-resistant staphylococcal aureus carrier. On 31-MAY-2011, the patient was vaccinated with a dose of MMR II (lot number: 667245/0961Z, expiration date: 21-JUL-2012) (dose and site of administration not reported). On approximately 07-JUN-2011, about a week after vaccination, the patient developed swollen neck glands and fever. The fever was in the 101 to 104 F range. On 17-JUN-2011, the patient was still experiencing fevers. On 19-JUN-2011, the physician started the patient on amoxicillin. The patient was still experiencing fevers of 103 to 104F and his neck was still swollen, red and tender. The patient was switched to AUGMENTIN. On 21-JUN-2011, the patient was admitted to the hospital. While hospitalized the patient had an abscess in his right lymph node drained (results not provided), strep culture was performed, and high white blood count showed 30, 000. The patient was discharged on 23-JUN-2011. The events were considered medically significant by registered nurse because they required intervention to prevent serious criteria. At the time of the report, the patient was recovering. Additional information has been requested.
Age: 20.0
Sex: M
Vaccine: SMALL
Symptoms: Injection site erythema, Injection site oedema, Injection site pain, Injection site warmth, Lymphadenopathy
Clinical narrative: left axilla lymph node swelling; left out arm upper with erythema/edema/warmth/pain localized around site
Age: 20.0
Sex: M
Vaccine: SMALL
Symptoms: Pain
Clinical narrative: left axilla lymph node swelling; left out arm upper with erythema/edema/warmth/pain localized around site
Age: 69.0
Sex: F
Vaccine: VARZOS
Symptoms: Pruritus, Swelling
Clinical narrative: Swelling, pruritus. Pt is taking prednisone 10 mg as directed by Dr and AUGMENTIN 875 mg twice daily from the same dr. to bring down the swelling and prevent infection.
Age: 39.0
Sex: F
Vaccine: PPV, TDAP
Symptoms: Body temperature increased, Fatigue, Injection site rash, Local reaction, Nausea
Clinical narrative: Lg local reaction & rash at injection site, T-103 (at 24hrs), fatigue, nausea.
Age: 50.0
Sex: F
Vaccine: TDAP
Symptoms: Chest pain, Diarrhoea, Headache, Injection site pain, Nausea
Clinical narrative: Fever, nausea, diarrhea & head/right sharp pains, body aches by following day, subsequent pain thoracic & left shoulder & arm, with possible dx brachial neuritis. Tx with IM DECADRON/KENALOG & Phys. Therapy.
Age: 50.0
Sex: F
Vaccine: TDAP
Symptoms: Pain, Pain in extremity, Pyrexia
Clinical narrative: Fever, nausea, diarrhea & head/right sharp pains, body aches by following day, subsequent pain thoracic & left shoulder & arm, with possible dx brachial neuritis. Tx with IM DECADRON/KENALOG & Phys. Therapy.
Sex: U
Vaccine: MMR
Symptoms: Autism
Clinical narrative: Information has been received from a Pharmacy Technician (Pharm. T.)/Healthcare Worker concerning a patient who on an unknown date was vaccinated with MMR II (albumin status and Lot # unspecified). It was reported that a family came into the pharmacy and stated that the patient (family member) received MMR II, some time after this, the patient was diagnosed with autism. It was unknown if the patient had sought any medical attention. At the time of report, the adverse event's outcome was unknown. Upon internal review, autism was determined to be other important medical events. Additional information has been requested.
Sex: F
Vaccine: MMR
Symptoms: Anaphylactic reaction
Clinical narrative: Information has been received from a registered pharmacist concerning a female patient, who on 30-JUN-2011 was vaccinated with a dose of MMR II (Lot # not reported). On 30-JUN-2011 the patient experienced anaphylaxis reaction. It was reported that the patient received ZYRTEC and famotidine as treatment for the adverse event. The patient sought medical attention in the emergency room. The patient's anaphylaxis reaction persisted. Anaphylaxis reaction was considered to be immediately life-threatening by the pharmacist. Additional information has been requested.
Age: 62.0
Sex: M
Vaccine: VARZOS
Symptoms: CSF culture, Culture negative, Drug eruption, Laboratory test normal, Polymerase chain reaction
Clinical narrative: Information has been received from a physician concerning a 62 year old male patient who on approximately 01-MAY-2011, "beginning of May", was vaccinated with a dose of ZOSTAVAX (Merck) (lot number, dose and site of administration not reported). On approximately 31-MAY-2011, "Around the end of May", the patient was admitted to the hospital with a rash across his forehead and into both ears and on both hands. Swabs of skin lesions as well as spinal fluid were examined. Lab cultures and PCR were negative for varicella zoster virus (VZV). Acyclovir was given for the treatment of the adverse events. The patient went home at the beginning of June when his lesions crusted over. At the time of the report, the patient was recovering. Follow up information has been received from the physician who reported that the rash was diagnosed as iododerma and not related to ZOSTAVAX (Merck). Additional information has been requested.
Age: 62.0
Sex: M
Vaccine: VARZOS
Symptoms: Rash, Scab, Skin lesion, Varicella virus test negative
Clinical narrative: Information has been received from a physician concerning a 62 year old male patient who on approximately 01-MAY-2011, "beginning of May", was vaccinated with a dose of ZOSTAVAX (Merck) (lot number, dose and site of administration not reported). On approximately 31-MAY-2011, "Around the end of May", the patient was admitted to the hospital with a rash across his forehead and into both ears and on both hands. Swabs of skin lesions as well as spinal fluid were examined. Lab cultures and PCR were negative for varicella zoster virus (VZV). Acyclovir was given for the treatment of the adverse events. The patient went home at the beginning of June when his lesions crusted over. At the time of the report, the patient was recovering. Follow up information has been received from the physician who reported that the rash was diagnosed as iododerma and not related to ZOSTAVAX (Merck). Additional information has been requested.
Age: 13.0
Sex: M
Vaccine: VARCEL
Symptoms: Blister, Erythema, Hypophagia, Induration, Local swelling
Clinical narrative: Mom states client ran fever same day of vaccine, 99 something per mom & just not feeling well.  Next day, area was red & swollen.  On 7/7/11 mom states area looks like a burn with blister.
Age: 13.0
Sex: M
Vaccine: VARCEL
Symptoms: Malaise, Pyrexia
Clinical narrative: Mom states client ran fever same day of vaccine, 99 something per mom & just not feeling well.  Next day, area was red & swollen.  On 7/7/11 mom states area looks like a burn with blister.
Age: 2.0
Sex: M
Vaccine: HEPA
Symptoms: Grand mal convulsion, Postictal state
Clinical narrative: Pt received hepatitis A shot at unknown PCP around 12pm. Mom said he was in usual state of health prior to that. Later that day, Mom took child to park and he developed a generalized tonic-clonic seizure that lasted around 2 minutes. He was transported to ED. He had brief post-ictal period but was back to baseline by 3pm.
Age: 3.0
Sex: M
Vaccine: PNC13
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Area where vaccine give became swollen, red and warm to the touch.
Age: 20.0
Sex: F
Vaccine: HEPA, YF
Symptoms: Pruritus, Urticaria
Clinical narrative: Hives (waist up) itching. Since Fri 7/8/11. Given ZYRTEC and advised to take BENADRYL at night. No respiratory issues.
Age: 80.0
Sex: F
Vaccine: VARZOS
Symptoms: Rash, Rash vesicular
Clinical narrative: SHINGLES-LIKE RASH ALONG ENTIRE UPPER ARM.
Age: 0.34
Sex: M
Vaccine: DTAPIPVHIB, PNC13, RV5
Symptoms: Blood calcium normal, Blood phosphorus normal, Blood urine present, Computerised tomogram abnormal, Convulsion
Clinical narrative: Vaccines given 7/7/11, developed fever 7/8/11 to 102.7 with multiple seizures on 7/8/11.
Age: 0.34
Sex: M
Vaccine: DTAPIPVHIB, PNC13, RV5
Symptoms: Full blood count, Laboratory test normal, Pyrexia, Urine analysis abnormal, Urine ketone body present
Clinical narrative: Vaccines given 7/7/11, developed fever 7/8/11 to 102.7 with multiple seizures on 7/8/11.
Age: 0.34
Sex: M
Vaccine: DTAPIPVHIB, PNC13, RV5
Symptoms: White blood cell count normal
Clinical narrative: Vaccines given 7/7/11, developed fever 7/8/11 to 102.7 with multiple seizures on 7/8/11.
Age: 30.0
Sex: F
Vaccine: HEP
Symptoms: Asthenia, Fatigue, Injection site pruritus, Injection site rash, Rash erythematous
Clinical narrative: About 24 hours after vaccine, pt noticed red bumps & itchy at injection site. Progressed over body with bumps. Day 7 & 8, weak & tired. Has not experienced SOB.
Age: 30.0
Sex: F
Vaccine: HEP
Symptoms: Rash generalised
Clinical narrative: About 24 hours after vaccine, pt noticed red bumps & itchy at injection site. Progressed over body with bumps. Day 7 & 8, weak & tired. Has not experienced SOB.
Sex: F
Vaccine: DTAPHEPBIP
Symptoms: Apnoea, Bradycardia, Oxygen saturation decreased, Respiratory disorder
Clinical narrative: Medication suspected of leading to the adverse reaction: PEDIARIX - combination vaccine--0.5ml/im- Reaction preventable-e.g., inappropriate or lack of dose adjustment, excessive dosing, known drug interaction, drug allergies, other contraindications, or inappropriate drug administration technique-; unknown. Type of reaction: Idiosyncratic - unanticipated rare adverse reaction not dose related, unexpected deterioration in respiratory status. Likelihood that the reaction was a result of the medication: Probable - reaction resolved when drug was discontinued/reaction could not be explained by existing clinical condition. Result of the reaction on the level of care: Oxygen administered. Incident Description: Within hours of PEDIARIX administration the patient's respiratory status declined resulting in an unusually elevated and unexpected number of events of apnea, desaturation and bradycardia. While some of these were self-resolved, at least 50% required stimulation and/or oxygen administration in a patient whose respiratory status had been stable in room air up to the time of the vaccine administration.
Age: 40.0
Sex: F
Vaccine: MMR, TDAP, VARCEL
Symptoms: Arthralgia, Pain in extremity, Pain of skin
Clinical narrative: ACHING PAIN IN FEET, ANKLES, LEGS, JOINTS ACHED IN KNEES & ANKLES, SKIN UNCOMFORTABLE TO TOUCH, NO FEVER, NO RASH, AND MUCH IMPROVED TODAY 7/11/2011. CLIENT HAS DOCTOR VISIT ON 7-12-2011.
Age: 1.0
Sex: F
Vaccine: HEPA, MMR, PNC13, VARCEL
Symptoms: Injection site erythema
Clinical narrative: Erythema, silver dollar size around varicella injection site in (L) upper thigh.
Age: 11.0
Sex: F
Vaccine: MNQ, TDAP, VARCEL
Symptoms: Injection site induration, Injection site pain, Injection site swelling, Rash vesicular
Clinical narrative: VARIVAX given 7/1/11. 7/2/11 - injection site swollen. In am, size of quarter. At 2pm doctor visit - swollen larger - 12 cm induration, mildly tender on (R) post triceps. Scant vesiculation present.
Age: 10.0
Sex: F
Vaccine: HPV4, TDAP, VARCEL
Symptoms: Injection site vesicles
Clinical narrative: Given VARIVAX 6/30/2011. Seen 7/3/11 with (2) 1 cm vesicles to (L) tricep.
Age: 68.0
Sex: F
Vaccine: VARZOS
Symptoms: Back pain, Burning sensation, Bursitis, Herpes zoster, Joint injection
Clinical narrative: I had a cortisone injection in left hip for bursitis and was prescribed Prednisone for 6 days by Dr. After taking the Prednisone I developed lower back pain (LT SIDE) and then developed burning of the left upper thigh. The burning persisted and on 7/7/11 at 4 PM, 8 pustules appeared on my upper left thigh. Since I was scheduled to leave out of town and it was Friday, I called the Dermatologist immediately and was seen that day at 11:30 AM. Dr. diagnosed it as Shingles and I was prescribed Valacyclovir 1 gm tablets 3x/day for 10 days.
Age: 68.0
Sex: F
Vaccine: VARZOS
Symptoms: Rash pustular
Clinical narrative: I had a cortisone injection in left hip for bursitis and was prescribed Prednisone for 6 days by Dr. After taking the Prednisone I developed lower back pain (LT SIDE) and then developed burning of the left upper thigh. The burning persisted and on 7/7/11 at 4 PM, 8 pustules appeared on my upper left thigh. Since I was scheduled to leave out of town and it was Friday, I called the Dermatologist immediately and was seen that day at 11:30 AM. Dr. diagnosed it as Shingles and I was prescribed Valacyclovir 1 gm tablets 3x/day for 10 days.
Age: 35.0
Sex: F
Vaccine: MMR
Symptoms: Body temperature increased, Ear pain, Neck pain, Nodule
Clinical narrative: Complaint of tender knot in back of neck with pain radiating to her left ear.  Temperature of 101
Age: 52.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Nodule, Oedema peripheral
Clinical narrative: Her arm was swollen and red. She reported she a a knot the size of a golf ball.
Age: 17.0
Sex: F
Vaccine: HPV4
Symptoms: Alopecia, Arthropathy, Butterfly rash, Cutaneous lupus erythematosus, Headache
Clinical narrative: Started having joint issues, headaches...after series completed, had a butterfly rash...Tested negative for rheumatoid, which does run in family....when 18-diagnosed and tested positive for both discoid lupus and systemic lupus...no family history of.
Age: 17.0
Sex: F
Vaccine: HPV4
Symptoms: Laboratory test abnormal, Rheumatoid factor negative, Skin disorder, Staphylococcal infection, Systemic lupus erythematosus
Clinical narrative: Started having joint issues, headaches...after series completed, had a butterfly rash...Tested negative for rheumatoid, which does run in family....when 18-diagnosed and tested positive for both discoid lupus and systemic lupus...no family history of.
Age: 70.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site warmth, Tenderness
Clinical narrative: red and slightly warm to touch at injection site, tender if bumped  advised patient 7/11/11 that Tylenol can be taken for the pain
Age: 14.0
Sex: F
Vaccine: TDAP, TDAP
Symptoms: Adverse reaction, Blood test abnormal, Headache, Inflammation, Injected limb mobility decreased
Clinical narrative: Headache no relief with Motrin lasted a continuous 13 days with varying intensity. Fever (101) trtmnt- Motrin. Followed by swelling at vaccine site - iced unable to move arm for 2 days.  Telephoned VAERS told to see urgent care - 06/22/2011 seen for reaction and told adverse preservative reaction should resolve itself. 06/28/2011 seen by primary MD blood work as headache still an issue - results show inflammation will redo bloodwork in 4 weeks.
Age: 14.0
Sex: F
Vaccine: TDAP, TDAP
Symptoms: Pyrexia, Reaction to preservatives, Vaccination site swelling
Clinical narrative: Headache no relief with Motrin lasted a continuous 13 days with varying intensity. Fever (101) trtmnt- Motrin. Followed by swelling at vaccine site - iced unable to move arm for 2 days.  Telephoned VAERS told to see urgent care - 06/22/2011 seen for reaction and told adverse preservative reaction should resolve itself. 06/28/2011 seen by primary MD blood work as headache still an issue - results show inflammation will redo bloodwork in 4 weeks.
Age: 14.0
Sex: F
Vaccine: TDAP, TDAP
Symptoms: Blood test abnormal, Body temperature increased, Fatigue, Headache, Inflammation
Clinical narrative: Headache no relief with Motrin lasted a continuous 13 days with varying intensity. Fever (101) trtmnt- Motrin. Followed by swelling at vaccine site - iced unable to move arm for 2 days.  Telephoned VAERS told to see urgent care - 06/22/2011 seen for reaction and told adverse preservative reaction should resolve itself. 06/28/2011 seen by primary MD blood work as headache still an issue - results show inflammation will redo bloodwork in 4 weeks.
Age: 14.0
Sex: F
Vaccine: TDAP, TDAP
Symptoms: Injected limb mobility decreased, Laboratory test, Malaise, Oedema peripheral
Clinical narrative: Headache no relief with Motrin lasted a continuous 13 days with varying intensity. Fever (101) trtmnt- Motrin. Followed by swelling at vaccine site - iced unable to move arm for 2 days.  Telephoned VAERS told to see urgent care - 06/22/2011 seen for reaction and told adverse preservative reaction should resolve itself. 06/28/2011 seen by primary MD blood work as headache still an issue - results show inflammation will redo bloodwork in 4 weeks.
Age: 24.0
Sex: F
Vaccine: ANTH, FLU3
Symptoms: Breast cancer stage I, Laboratory test abnormal, Malaise, Pathology test
Clinical narrative: Received # ANTHRAX vaccines in 1998 and 1999. Developed breast cancer in 2008 and oncologist said he could not be 100% sure that the ANTHRAX vaccine did not cause the cancer so she should avoid it. Has not felt as well since receiving the ANTHRAX vaccines as before she received them.
Age: 66.0
Sex: M
Vaccine: VARZOS
Symptoms: Pain
Clinical narrative: Patient called 7/8/11 and told RPh on duty still having residual pain from ZOSTAVAX injection given on 5/28/11; was told to F-up w/MD and pt. said he had and she requested him to get a MRI.
Age: 53.0
Sex: F
Vaccine: TDAP
Symptoms: Chills, Headache, Injection site erythema, Injection site induration, Injection site pain
Clinical narrative: Pt described Pain and swelling at L deltoid injection site. Erythema and induration noted, max 5cm x 12cm. low grade fever, body aches, chills and mild head ache. Pt reports mild pain from injection site.
Age: 53.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site swelling, Pain, Pyrexia
Clinical narrative: Pt described Pain and swelling at L deltoid injection site. Erythema and induration noted, max 5cm x 12cm. low grade fever, body aches, chills and mild head ache. Pt reports mild pain from injection site.
Age: 22.0
Sex: F
Vaccine: DTAP
Symptoms: Body temperature increased, Diarrhoea, Heart rate increased, Hypertension, Vomiting
Clinical narrative: High Blood Pressure and Pulse Temperature 102.3 Diarrhea  Vomiting
Age: 5.0
Sex: M
Vaccine: DTAP, HEPA, IPV, MMRV
Symptoms: VIIth nerve paralysis
Clinical narrative: Bell Palsy
Age: 11.0
Sex: M
Vaccine: MEN, TDAP
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Pt had swelling, heat over the injection, and large erythematous region over the injection site
Age: 0.57
Sex: F
Vaccine: DTAPHEPBIP
Symptoms: Pyrexia
Clinical narrative: Fever spike 101.3
Age: 23.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling, Injection site warmth
Clinical narrative: Site became red, swollen, warm to touch, the injection site was tender to touch and stiff. As of 7/11/11, arm is no longer tender but site remains red, swollen, warm to touch, and now itches.
Age: 23.0
Sex: F
Vaccine: TDAP
Symptoms: Musculoskeletal stiffness
Clinical narrative: Site became red, swollen, warm to touch, the injection site was tender to touch and stiff. As of 7/11/11, arm is no longer tender but site remains red, swollen, warm to touch, and now itches.
Age: 28.0
Sex: F
Vaccine: TDAP, TDAP
Symptoms: Headache, Laboratory test, Musculoskeletal stiffness, Pain in extremity, Pyrexia
Clinical narrative: ON CALL NOTE 5:45 pm. Patients reports fever to 101.5, headache, stiff neck, severe arm pain over the past few hours. She received Tdap vaccine yesterday. I advised ER evaluation for above symptoms and fever.
Age: 28.0
Sex: F
Vaccine: TDAP, TDAP
Symptoms: Ultrasound scan, X-ray
Clinical narrative: ON CALL NOTE 5:45 pm. Patients reports fever to 101.5, headache, stiff neck, severe arm pain over the past few hours. She received Tdap vaccine yesterday. I advised ER evaluation for above symptoms and fever.
Age: 28.0
Sex: F
Vaccine: TDAP, TDAP
Symptoms: Bacterial infection, Blood test, Musculoskeletal stiffness, Oedema peripheral, Pyrexia
Clinical narrative: ON CALL NOTE 5:45 pm. Patients reports fever to 101.5, headache, stiff neck, severe arm pain over the past few hours. She received Tdap vaccine yesterday. I advised ER evaluation for above symptoms and fever.
Age: 5.0
Sex: F
Vaccine: PNC
Symptoms: Injection site erythema, Injection site swelling, Pyrexia
Clinical narrative: fever, redness, swelling to injection site site measuring 13 1/2cm by 10 1/2 cm
Age: 4.0
Sex: M
Vaccine: DPP, HEPA, PNC13, VARCEL
Symptoms: Dyskinesia
Clinical narrative: Neck roll with shoulder shrug throughout day. One month later instead of one at a time, he now does it three times or so when he does it, and this is throughout the day. Have made appointment with neurologist to look at him. Dr. dismissed it as emotional or Tourettes.
Age: 20.0
Sex: F
Vaccine: ANTH, TYP
Symptoms: Chills, Flank pain, Lethargy, Pyrexia
Clinical narrative: Presented to clinic with chills, fever 103 degrees, lethargy, flank pain on palpation.
Age: 58.0
Sex: M
Vaccine: ANTH
Symptoms: Injection site erythema, Injection site oedema, Injection site pain
Clinical narrative: Erythema, Pain, Edema over Lt Deltoid and upper arm.  Dx of cellulitis.  Tx'd with Rifampin / Septra DS
Age: 18.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Convulsion, Pallor
Clinical narrative: Pt went pale and started seizing up for about 20 secs. Time was around 1120 am 11 July 2011. Pt given oxygen and laid down. Pt returned to normal after doctor cleared.
Age: 0.3
Sex: M
Vaccine: DTAPIPVHIB, RV5
Symptoms: Haematochezia, Occult blood positive
Clinical narrative: Hematochezia that started 1 day after the vaccine was administered.
Age: 5.0
Sex: M
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Convulsion
Clinical narrative: 1 minute generalized seizure.
Age: 0.5
Sex: M
Vaccine: DTAPIPVHIB, HEP, PNC13, RV5
Symptoms: Rash macular
Clinical narrative: Mild faint erythematous macules on posterior neck and upper trunk that developed several hours after receiving vaccinations.
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Pain, Skin warm, Swelling
Clinical narrative: Received ZOSTAVAX shot on 7/8/11. Day after was sore, hot & red. Redness spread. Reported back to clinic on 7/11/11. Had an area 5mm x 11mm of hot, red area, some swelling. Treated with KEFLEX 500mg QID x 10 days.
Age: 58.0
Sex: F
Vaccine: HEP
Symptoms: Unevaluable event
Clinical narrative: None stated.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Redness & swelling appeared on 7/9/11 to upper (L) thigh, was painful to touch, no pain now. (1.5 cm induration & 8x4 cm erythema now). F/u w/PCP if fever or increased redness or tenderness.